How is your doctor using this to objectively determine your gait problems and then assign stroke protocols to correct them? Oh, your doctor is doing none of that? Then you don't have a functioning stroke doctor.
Oops, I'm not playing by the polite rules of Dale Carnegie, 'How to Win Friends and Influence People'.
Telling supposedly smart stroke medical persons they know nothing about stroke is a no-no even if it is true.
Politeness will never solve anything in stroke. Yes, I'm a bomb thrower and proud of it. Someday a stroke 'leader' will try to ream me out for making them look bad by being truthful, I look forward to that day.
Gait in cerebral small vessel disease, pre-dementia, and dementia: A systematic review
Abstract
Background:
The
interrelationships between gait, cerebral small vessel disease (CSVD),
and cognitive impairments in aging are not well-understood—despite their
common co-occurrence.
Objective:
To
systematically review studies of gait impairment in CSVD, pre-dementia,
and dementia, and to identify key gaps for future research and novel
pathways toward intervention.
Methods:
A
Preferred Reporting Items for Systematic Reviews and Meta-Analyses
(PRISMA)-guided search strategy was implemented in PubMed to identify
relevant studies. Potential articles (n = 263) published prior to 1
December 2021 were screened by two reviewers. Studies with sample sizes
>20 and including some adults over > 65 years (n = 202) were
included.
Results:
The
key findings were that (1) adverse gait and cognitive outcomes were
associated with several (rather than select) CSVD pathologies
distributed across the brain, and (2) poor gait and CSVD pathologies
were more strongly associated with dementia with a vascular, rather than
an Alzheimer’s disease-related, cause.
Discussion:
A
better understanding of the interrelationships between gait performance
in CSVD, pre-dementia, and dementia requires studies examining (1)
comprehensive patterns in the clinical manifestations of CSVD, (2)
racially/ethnically diverse samples, (3) samples followed for extended
periods of time or across the adult life span, (4) non-traditional CSVD
neuroimaging markers (e.g. resting-state functional magnetic resonance
imaging (fMRI)), and (5) continuous (e.g. wearable sensors) and complex
(e.g. dual-task) walking performance.
Get full access to this article
View all access and purchase options for this article.
No comments:
Post a Comment